Fig. S1. Mass spectra from MALDI-MSI and DESI-MSI experiments with the average spectra from GF and SPF mouse brains overlaid. Fig. S2 . MALDI-MSI of organs and blood recovered from C57BL/6 wild-type mice indicated that m/z 160.1 was located systemically in all organs tested as well as present in whole blood. Fig. S3 . MALDI-MSI of colon sections from mice treated with antibiotics for 7 days demonstrates that the metabolite at m/z 160.1 is decreased in the colon of antibiotic-treated mice compared to controls. Fig. S4 . MS/MS analysis of the metabolite found in the brain and the metabolite of the same m/z (160.133) produced by C. clostridioforme was undertaken. Fig. S5 . Mass spectra from the MS/MS analysis of the synthesized standard 5-AVAB compared to the endogenous metabolite in the brain at m/z 160.133. Fig. S6 . Overlap of the ion images of m/z 160.1 and m/z 162.1 (carnitine) from SPF and GF mouse brains and abundance of m/z 160.1 from SPF and GF brains and off-tissue negative control area. Fig. S7. Additional information to fig. S5 . Fig. S8 . OCR was used as an indicator of FAO in the presence of 3M-4-TMAB and 4-TMAP at the indicated concentrations and in the absence of carnitine supplementation. Fig. S9 . Average mass spectra from MALDI-MSI and DESI-MSI results showing peaks at m/z 160.133 (3M-4-TMAB/4-TMAP) and m/z 162.112 (carnitine) from GF and SPF mouse brains. Table S1 . Summary of the top correlations with Pearson's coefficient > 0.5 for m/z 160.1 (3M-4-TMAB/4-TMAP) for the SPF brain tissue sections shown in Fig. 4. 
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Fig. S1. Mass spectra from MALDI-MSI and DESI-MSI experiments with the average spectra from GF and SPF mouse brains overlaid. Fig. S2 . MALDI-MSI of organs and blood recovered from C57BL/6 wild-type mice indicated that m/z 160.1 was located systemically in all organs tested as well as present in whole blood. Fig. S3 . MALDI-MSI of colon sections from mice treated with antibiotics for 7 days demonstrates that the metabolite at m/z 160.1 is decreased in the colon of antibiotic-treated mice compared to controls. Fig. S4 . MS/MS analysis of the metabolite found in the brain and the metabolite of the same m/z (160.133) produced by C. clostridioforme was undertaken. Fig. S5 . Mass spectra from the MS/MS analysis of the synthesized standard 5-AVAB compared to the endogenous metabolite in the brain at m/z 160.133. Fig. S6 . Overlap of the ion images of m/z 160.1 and m/z 162.1 (carnitine) from SPF and GF mouse brains and abundance of m/z 160.1 from SPF and GF brains and off-tissue negative control area. .  Table S1 . Summary of the top correlations with Pearson's coefficient > 0.5 for m/z 160.1 (3M-4-TMAB/4-TMAP) for the SPF brain tissue sections shown in Fig. 4 . Figure 5 ) with the average spectra from GF and SPF mice brains overlaid (a). The spectra show similar peaks are detected in the GF and SPF mice, with the peak at m/z 160.133 not visible in the GF spectra. A zoomed average spectrum from MALDI-MSI and DESI-MSI experiments show the peak at m/z 160.133 (b). There are several peaks present in the high-resolution DESI-MSI spectrum, which could not be resolved by MALDI-MSI. These unresolved peaks would contribute to apparent detection for m/z 160.1 in the GF samples. A comparison of MALDI-MSI average spectra from GF brains, SPF brains and a region off-tissue, demonstrate that the m/z 160.1 peak from the GF brain is comparable to a spectra acquired from a region off-tissue (c). shown, m/z 50-180, but at the higher energies (HCD50-100) the spectrum is zoomed to show a range of m/z 50-120. At HCD 65 and 75 a distinct difference in the peak at 55.055 is noted, with it significantly lower in 5-AVAB compared to m/z 160.133 from the brain. Differential thresholding was necessary to enable co-localization analysis of m/z 160.1 and carnitine (m/z 162.1) in GF brain due to the fact that the signal detected in the GF brain for m/z 160.1 was negligible (i.e, less than that of the off target control) as depicted in (c). All mice from all conditions were thresholded separately to account for potential variances in intensities between tissue sections related to minor differences in concentrations between animals. A graph of abundance of signal at m/z 160.1 is shown to compare levels in the corpus callosum of the SPF brain (area of high abundance of m/z 160.1), the corpus callosum of the GF brain and an off tissue negative control area (c). The graphs shows the level of signal detected in GF brains is similar to levels off-tissue, therefore the binary image generated for GF brains is likely generated from random background signal. Levels in GF and negative control regions are of comparable background abundance. MS/MS analysis was performed on SPF and GF brains to investigate the structural relationship between signal observed in both tissues (e). Signal from SPF brain is consistent with data recorded for 3M-4-TMAB/4-TMAP. No MS/MS spectrum could be obtained on GF brain. This suggests that low level signal observed in background and GF mice is an isobaric compound of different chemical nature. This is further suggested by comparison of data shown in Figure 4 and Figure   S7 . Spatial distribution of signal at m/z 160 in GF mice is different from that seen in SPF mice, suggesting compounds of different chemical nature and function. Furthermore, the identification of the metabolites was performed by NMR and the structure obtained is consistent with results from MS/MS analysis from brain tissue. Figure S1 (e) shows that prominent fragments for 3M-4-TMAB/4-TMAP are not found in GF brains and off-tissue, consistent with the absence of these metabolites from GF tissues. Summary of the top correlations with a Pearson's coefficient > 0.5 for m/z 160.1 (3M-4-TMAB/4-TMAP) for the SPF brain tissue sections shown in Figure 4 . The third highest correlation is for carnitine m/z 162.1 (indicated in bold) for all three SPF brain tissue sections.
The results show three biological replicates.
